Welcome to LookChem.com Sign In|Join Free
  • or
4-Chloro-7-(trifluoromethyl)quinoline is a white to light yellow crystal powder that serves as a reagent in the chemical synthesis process. It is a derivative of quinoline, a nitrogen-containing aromatic compound, with a chlorine atom at the 4th position and a trifluoromethyl group at the 7th position. 4-Chloro-7-(trifluoromethyl)quinoline is known for its potential applications in the pharmaceutical industry due to its unique chemical properties.

346-55-4

Post Buying Request

346-55-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

346-55-4 Usage

Uses

Used in Pharmaceutical Industry:
4-Chloro-7-(trifluoromethyl)quinoline is used as a reagent for the preparation of piperazinylquinolines, which are known to exhibit breast cancer inhibitory properties. 4-Chloro-7-(trifluoromethyl)quinoline plays a crucial role in the development of new therapeutic agents targeting breast cancer, contributing to the advancement of cancer treatment options.
In the synthesis of piperazinylquinolines, 4-Chloro-7-(trifluoromethyl)quinoline serves as a key intermediate, allowing for the creation of molecules with potential anti-cancer activities. Its chemical properties make it a valuable component in the development of novel pharmaceutical compounds, particularly those aimed at combating breast cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 346-55-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,4 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 346-55:
(5*3)+(4*4)+(3*6)+(2*5)+(1*5)=64
64 % 10 = 4
So 346-55-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H18F3NO4/c1-14(2,3)23-13(22)19-11(12(20)21)8-9-6-4-5-7-10(9)15(16,17)18/h4-7,11H,8H2,1-3H3,(H,19,22)(H,20,21)

346-55-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (186023)  4-Chloro-7-(trifluoromethyl)quinoline  98%

  • 346-55-4

  • 186023-5G

  • 1,620.45CNY

  • Detail
  • Aldrich

  • (186023)  4-Chloro-7-(trifluoromethyl)quinoline  98%

  • 346-55-4

  • 186023-25G

  • 5,601.96CNY

  • Detail

346-55-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-7-(trifluoromethyl)quinoline

1.2 Other means of identification

Product number -
Other names 4-chloro-7-trifluoroquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:346-55-4 SDS

346-55-4Relevant academic research and scientific papers

Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents

Bhagat, Shweta,Arfeen, Minhajul,Das, Gourav,Ramkumar, Mridula,Khan, Shabana I.,Tekwani, Babu L.,Bharatam, Prasad V.

, (2019/08/02)

Guanylthiourea (GTU) has been identified as an important antifolate antimalarial pharmacophore unit, whereas, 4-amino quinolones are already known for antimalarial activity. In the present work molecules carrying 4-aminoquinoline and GTU moiety have been designed using molecular docking analysis with PfDHFR enzyme and heme unit. The docking results indicated that the necessary interactions (Asp54 and Ile14) and docking score (?9.63 to ?7.36 kcal/mmol) were comparable to WR99210 (?9.89 kcal/mol). From these results nine molecules were selected for synthesis. In vitro analysis of these synthesized compounds reveal that out of the nine molecules, eight show antimalarial activity in the range of 0.61–7.55 μM for PfD6 strain and 0.43–8.04 μM for PfW2 strain. Further, molecular dynamics simulations were performed on the most active molecule to establish comparative binding interactions of these compounds and reference ligand with Plasmodium falciparum dihydrofolate reductase (PfDHFR).

A convenient preparation of heteroaryl sulfonamides and sulfonyl fluorides from heteroaryl thiols

Wright, Stephen W.,Hallstrom, Kelly N.

, p. 1080 - 1084 (2007/10/03)

Heteroaromatic thiols may be oxidized to the sulfonyl chloride at low temperature (-25 °C) by using 3.3 equiv of aqueous sodium hypochlorite. The reaction is rapid, avoids the use of chlorine gas, and succeeds with substrates that have previously been found to afford little or none of the sulfonamide product with other procedures. The method allows the preparation of the sulfonyl fluorides, which are stable enough to be purified and stored, making them potentially useful monomers in parallel chemistry efforts.

Synthesis of ring-substituted 4-aminoquinolines and evaluation of their antimalarial activities

Madrid, Peter B.,Sherrill, John,Liou, Ally P.,Weisman, Jennifer L.,DeRisi, Joseph L.,Guy, R. Kiplin

, p. 1015 - 1018 (2007/10/03)

A simple two-step synthesis method was used to make 51 B-ring-substituted 4-hydroxyquinolines allowing analysis of the effect of ring substitutions on inhibition of growth of chloroquine sensitive and resistant strains of Plasmodium falciparum, the dominant cause of malaria morbidity. Substituted quinoline rings other than the 7-chloroquinoline ring found in chloroquine were found to have significant activity against the drug-resistant strain of P. falciparum W2.

QUINOLINE COMPOUNDS AND THEIR USES

-

Page/Page column 38, (2008/06/13)

The present invention provides quinoline compounds that inhibit the IgE receptor signaling cascade that leads to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE receptor signaling cascade.

NOVEL QUINOLINE DERIVATIVES

-

Page/Page column 46, (2008/06/13)

The invention relates to compounds represented by Formula (I): and to pharmaceutically acceptable salts or solvates of said compounds, wherein each of A, R3-8, X3, X5, m, and n are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).

Process for the preparation of fluorinated heterocyclic compounds

-

, (2008/06/13)

A method of fluorinating a heterocyclic organic compound comprises the step of reacting a heterocyclic compound with elemental fluorine in the presence of another halogen. The reaction may be conducted in the presence of a base.

Structure-activity relationships for antiplasmodial activity among 7- substituted 4-aminoquinolines

De, Dibyendu,Krogstad, Frances M.,Byers, Larry D.,Krogstad, Donald J.

, p. 4918 - 4926 (2007/10/03)

Aminoquinolines (AQs) with diaminoalkane side chains (-HNRNEt2) shorter or longer than the isopentyl side chain [-HNCHMe(CH2)3NEt2] of chloroquine are active against both chloroquine-susceptible and -resistant Plasmodium falciparum. (De, D.; et al. Am. J. Trop. Med. Hyg. 1996, 55, 579-583). In the studies reported here, we examined structure-activity relationships (SARs) among AQs with different N,N-diethyldiaminoalkane side chains and different substituents at the 7-position occupied by Cl in chloroquine. 7-Iodo- and 7- bromo-AQs with diaminoalkane side chains [-HN(CH2)2NEt2, -HN(CH2)3NEt2, or -HNCHMeCH2NEt2] were as active as the corresponding 7-chloro-AQs against both chloroquine-susceptible and -resistant P. falciparum (IC50s of 3-12 nM). In contrast, with one exception, 7-fluoro-AQs and 7-trifluoromethyl-AQs were less active against chloroquine-susceptible P. falciparum (IC50s of 15-50 nM) and substantially less active against chloroquine-resistant P. falciparum (IC50s of 18-500 nM). Furthermore, most 7-OMe-AQs were inactive against both chloroquine-susceptible (IC50s of 17-150 nM) and -resistant P. falciparum (IC50s of 90-3000 nM).

Addition of nitroalkanes toortho-halonitrobenzenes: A new synthesis of 4-chloro-7-(trifluoromethyl)quinoline

Gregory Reid,Reny Runge, Jean H.

, p. 1093 - 1096 (2007/10/02)

Base-mediated reaction of ortho-nitroaryl chlorides and fluorides with nitroalkanes followed by an oxidative Nef reaction provides aryl ketones. With this simple procedure, methylketone 6 was prepared in 91% yield. 6 was then converted in three steps (60-65% yield) to 4-chloro-7-(trifluoromethyl)quinoline (2), an intermediate in the synthesis of the antihypertensive agent losulazine (U-54,669, 1).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 346-55-4